Skip to main content
. 2015 Feb 18;14:24. doi: 10.1186/s12933-015-0189-0

Table 3.

Hazard ratios for mortality associated with elevated body mass index in patients with and without diabetes stratified by prescribed medications before and after myocardial infarction

No diabetes (n=2864) Diabetes (n=1190)
HR [95% CI] p-value HR [95% CI] p-value
Statins prior AMI Normal weight 1.0 1.0
Overweight 0.81 [0.44-1.52]a 0.5179 0.51 [0.29-0.89]b 0.0180
Obesity 0.59 [0.26-1.35]a 0.2115 0.82 [0.46-1.47]b 0.5102
No statins prior AMI Normal weight 1.0 1.0
Overweight 0.71 [0.55-0.92]a 0.0082 1.04 [0.71-1.52]b 0.8456
Obesity 0.66 [0.47-0.92]a 0.0131 1.09 [0.73-1.64]b 0.6697
Four medications at dischargec Normal weight 1.0 1.0
Overweight 0.76 [0.56-1.03]e 0.0805 0.52 [0.34-0.80]f 0.0027
Obesity 0.56 [0.37-0.86]e 0.0072 0.82 [0.54-1.26]f 0.3745
Less than four medications at discharged Normal weight 1.0 1.0
Overweight 0.67 [0.47-0.95]e 0.0260 1.21 [0.71-1.89]f 0.4095
Obesity 0.70 [0.44-1.11]e 0.1320 1.03 [0.62-1.73]f 0.9062

HR=Hazard Ratio, CI=Confidence Interval, AMI=Acute Myocardial Infarction, BMI=Body Mass Index.

aParsimonious model adjusted for sex, age, stroke, smoking, re-infarction, any reperfusion treatment (coronary artery bypass surgery, percutaneous coronary intervention (PCI) or thrombolysis), beta-blockers (medication prior AMI), all four medications at discharge (antiplatelet agents, beta-blockers, Angiotensin-converting enzyme inhibitors (ACEIs)/Angiotensin receptor blockers (ARBs), statins), left ventricular ejection fraction (<30% versus ≥ 30%).

bParsimonious model adjusted for sex, age, hyperlipidemia, re-infarction, any reperfusion treatment, all four medications at discharge.

cEvidence-based medications (EBMs): Antiplatelet agents, beta-blockers, ACEIs/ARBs, statins.

dEither antiplatelet agents, beta-blockers, ACEIs/ARBs, statins or a combination of two or three of these medications.

eParsimonious model adjusted for sex, age, stroke, smoking, re-infarction, any reperfusion treatment, beta-blockers (medication prior AMI), left ventricular ejection fraction (<30% versus ≥ 30%).

fParsimonious model adjusted for sex, age, hyperlipidemia, re-infarction, any reperfusion treatment, statins (medication prior AMI).